Alignment Healthcare, Inc. (NASDAQ:ALHC) Receives Consensus Rating of "Moderate Buy" from Brokerages

Key Points

• Alignment Healthcare, Inc. has received a consensus rating of "Moderate Buy" from thirteen brokerages, with an average target price of $19.05.
• Recent insider activity includes a significant sale of 6.2 million shares by Director Atlantic L. General, which reflects a 20.25% decrease in ownership.
• The company reported a 49% increase in quarterly revenue year-over-year, with earnings per share of $0.07, surpassing analysts' expectations.

Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) have been given an average recommendation of "Moderate Buy" by the thirteen research firms that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation, seven have given a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $19.05.

ALHC has been the topic of a number of recent analyst reports. The Goldman Sachs Group started coverage on shares of Alignment Healthcare in a research note on Tuesday, October 14th. They issued a "buy" rating and a $21.00 target price on the stock. Zacks Research upgraded Alignment Healthcare from a "hold" rating to a "strong-buy" rating in a research note on Monday, September 29th. Weiss Ratings reissued a "sell (d-)" rating on shares of Alignment Healthcare in a report on Friday. Barclays upgraded Alignment Healthcare from an "underweight" rating to an "equal weight" rating and increased their target price for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. Finally, KeyCorp raised Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price objective on the stock in a research report on Monday, August 25th.

Insider Activity

In other news, Director Atlantic (Aln Hlth) L. General sold 6,246,096 shares of the business's stock in a transaction on Wednesday, September 17th. The stock was sold at an average price of $16.01, for a total value of $99,999,996.96. Following the completion of the transaction, the director directly owned 24,596,079 shares of the company's stock, valued at $393,783,224.79. The trade was a 20.25% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, President Dawn Christine Maroney sold 215,662 shares of the business's stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total value of $3,539,013.42. Following the sale, the president directly owned 1,797,237 shares of the company's stock, valued at approximately $29,492,659.17. This trade represents a 10.71% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 7,443,207 shares of company stock worth $119,848,080 in the last quarter. Insiders own 7.00% of the company's stock.

Hedge Funds Weigh In On Alignment Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Amalgamated Bank grew its holdings in shares of Alignment Healthcare by 21.6% in the 1st quarter. Amalgamated Bank now owns 3,466 shares of the company's stock valued at $65,000 after buying an additional 616 shares during the period. Tidal Investments LLC boosted its position in Alignment Healthcare by 4.9% in the second quarter. Tidal Investments LLC now owns 18,094 shares of the company's stock valued at $253,000 after buying an additional 852 shares in the last quarter. Ballentine Partners LLC raised its stake in Alignment Healthcare by 8.6% during the first quarter. Ballentine Partners LLC now owns 11,674 shares of the company's stock worth $217,000 after buying an additional 924 shares during the last quarter. MCF Advisors LLC grew its holdings in Alignment Healthcare by 87.6% in the first quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock worth $40,000 after purchasing an additional 1,011 shares during the period. Finally, Cresset Asset Management LLC grew its holdings in shares of Alignment Healthcare by 0.6% during the first quarter. Cresset Asset Management LLC now owns 287,565 shares of the company's stock valued at $5,354,000 after buying an additional 1,797 shares during the last quarter. 86.19% of the stock is owned by institutional investors.

Alignment Healthcare Stock Performance

Shares of Alignment Healthcare stock opened at $17.51 on Friday. The firm's 50-day simple moving average is $16.66 and its 200-day simple moving average is $15.58. Alignment Healthcare has a 1 year low of $10.18 and a 1 year high of $21.06. The firm has a market cap of $3.47 billion, a PE ratio of -62.53 and a beta of 1.18. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.66 and a current ratio of 1.66.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, beating analysts' consensus estimates of ($0.07) by $0.14. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $960.25 million. During the same quarter last year, the firm posted ($0.13) EPS. The company's quarterly revenue was up 49.0% on a year-over-year basis. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities analysts forecast that Alignment Healthcare will post -0.69 earnings per share for the current fiscal year.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.